Author statistical analysis plans in conjunction with the clinical team
Responsible for biostatistical activities for a complex portfolio of clinical studies for gene therapy programs.
Where applicable, oversees and directs statistical analysis, document review and data inclusion for NDA submissions of assigned studies by collaborating with own team, other Biostatistics team members, CROs, and cross-functional partners. Ensures appropriate statistical consultation on trial design and study endpoints and timely and well-executed authoring of statistical analysis plans.
Align the requirements for data reporting, tables, listings, and figures required for interim and final reports, including topline reports and final clinical study reports.
Where applicable, oversees, and contributes to completion of all technical and operational statistical activities for a portfolio of clinical trials. Directs internal and external teams in the definition, execution and completion of statistical activities for disease or therapeutic area products of considerable complexity.
Contribute to clinical study designs and clinical development planning for the portfolio.
Where applicable, advises or otherwise ensures timely and appropriate advice to internal and external partners on statistical analysis strategies, reliability of measurements and identifiability of models, and interpretation and presentation of statistical results.
Ensures timely and appropriate gathering, organization, and analysis of different data sources to enable delivery of the statistical analysis plan and clinical study endpoints for clinical studies.
Reviews and approves biostatistical input into clinical development documentation, scientific publications and presentations and regulatory documentation.
Typically takes a lead in special projects that can benefit multiple biostatistics team members, such as new methodologies, processes, technology and other tools, and may also lead the development and / or implementation of SOPs and related documentation.
Provide statistical leadership in clinical study team setting.
May independently present at department, project team, or Sr. Management meetings.
Adheres to regulatory requirements of study conduct, statistical analysis principles, industry standards, and LEXEO’s SOPs.Â